Epidemiology of invasive meningococcal disease in Cyprus 2004 to 2018

Maria Koliou1,2, Diamanto Kasapi1, Stella Mazeri3,4

  • 1Medical School, University of Cyprus, Nicosia, Cyprus.

Insights

Invasive meningococcal disease (IMD) in Cyprus shows low incidence but significant mortality, with Serogroup B most common. Rising W and Y serogroups necessitate ongoing immunisation program evaluation.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Invasive meningococcal disease (IMD) continues to cause significant mortality and long-term health issues despite advances in management.
  • Understanding the specific epidemiological and clinical patterns of IMD is crucial for effective public health interventions.

Purpose of the Study:

  • To detail the epidemiology and clinical features of IMD cases in Cyprus.
  • To evaluate the current immunisation programs in relation to IMD trends.

Main Methods:

  • A retrospective analysis of all notified IMD cases in Cyprus from 2004 to 2018.
  • Collection of demographic, epidemiological, clinical, and microbiological data for each case.
  • Univariable logistic regression was used to identify mortality risk factors.

Main Results:

  • 54 IMD cases were recorded, with an overall incidence of 0.4 per 100,000 population.
  • Infants and adolescents exhibited the highest incidence rates.
  • The case fatality rate was 10.4%, with Serogroups W and Y being responsible for most fatal outcomes, despite Serogroup B being the most frequent overall.

Conclusions:

  • IMD, while having a low incidence in Cyprus, remains a critical cause of illness and death.
  • Serogroup B is predominant, but increasing incidence of Serogroups W and Y is noted.
  • Continuous monitoring of IMD cases and regular assessment of immunisation strategies by the National Immunization Technical Advisory Group (NITAG) are vital for disease control.